(1)

Commission Directive 2012/38/EU of 23 November 2012 amending Directive 98/8/EC of the European Parliament and of the Council to include cis-Tricos-9-ene as an active substance in Annex I thereto (1) is to be incorporated into the EEA Agreement.

(2)

Commission Directive 2012/40/EU of 26 November 2012 correcting Annex I to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (2) is to be incorporated into the EEA Agreement.

(3)

Commission Directive 2012/41/EU of 26 November 2012 amending Directive 98/8/EC of the European Parliament and of the Council to extend the inclusion in Annex I thereto of the active substance nonanoic acid to product type 2 (3) is to be incorporated into the EEA Agreement.

(4)

Commission Directive 2012/42/EU of 26 November 2012 amending Directive 98/8/EC of the European Parliament and of the Council to include hydrogen cyanide as an active substance in Annex I thereto (4) is to be incorporated into the EEA Agreement.

(5)

Commission Directive 2012/43/EU of 26 November 2012 amending certain headings of Annex I to Directive 98/8/EC of the European Parliament and of the Council (5) is to be incorporated into the EEA Agreement.

(6)

Commission Directive 2013/3/EU of 14 February 2013 amending Directive 98/8/EC of the European Parliament and of the Council to extend the inclusion in Annex I thereto of the active substance thiamethoxam to product-type 18 (6) is to be incorporated into the EEA Agreement.

(7)

Commission Directive 2013/4/EU of 14 February 2013 amending Directive 98/8/EC of the European Parliament and of the Council to include Didecyldimethylammonium Chloride as an active substance in Annex I thereto (7) is to be incorporated into the EEA Agreement.

(8)

Commission Directive 2013/5/EU of 14 February 2013 amending Directive 98/8/EC of the European Parliament and of the Council to include pyriproxyfen as an active substance in Annex I thereto (8) is to be incorporated into the EEA Agreement.

(9)

Commission Directive 2013/6/EU of 20 February 2013 amending Directive 98/8/EC of the European Parliament and of the Council to include diflubenzuron as an active substance in Annex I thereto (9) is to be incorporated into the EEA Agreement.

(10)

Commission Decision 2012/728/EU of 23 November 2012 concerning the non-inclusion of bifenthrin for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (10) is to be incorporated into the EEA Agreement.

(11)

Commission Decision 2013/85/EU of 14 February 2013 concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (11) is to be incorporated into the EEA Agreement.

(12)

Annex II to the EEA Agreement should therefore be amended accordingly,

(1)

the following indents are added in point 12n (Directive 98/8/EC of the European Parliament and of the Council):

(2)

the following points are inserted after point 12zzl (Commission Decision 2012/483/EU):